Earlens

company

About

Earlens is a medical technology company transforming the hearing experience with the only direct sound delivery system.

  • 101 - 250

Details

Last Funding Type
Series C
Last Funding Money Raised
$34M
Industries
Health Care,Medical,Medical Device
Founded date
Oct 1, 2005
Number Of Employee
101 - 250
Operating Status
Active

Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process.

The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$194M
Earlens has raised a total of $194M in funding over 2 rounds. Their latest funding was raised on Oct 22, 2018 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 22, 2018 Series D $87M 6 Detail
Jun 5, 2017 Series C $73M 1 Detail
Jun 16, 2016 Series C $34M 1 Detail

Investors

Number of Lead Investors
Number of Investors
7
Earlens is funded by 7 investors. Sightline Healthcare Opportunity and MS Pace LP are the most recent investors.
Investor Name Lead Investor Funding Round
Sightline Healthcare Opportunity Series D
MS Pace LP Series D
GDN Holdings Series D
Baltisches Haus Series D
ARCH Healthcare Fund Series D
Relativity Healthcare Partners Series D
Medtronic Series C